Drug intelligence / Profile preview

REGENERELLE

Development stage
Preclinical
Lead developer
Regenerelle
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous, Local Injection
01

Overview

REGENERELLE is an allogeneic cell therapy product developed by ATVentureCenter (operating under The Crowley Center for Regenerative & Biotherapeutics) consisting of human mesenchymal stem/stromal cells (hMSCs) derived from the Wharton's Jelly of umbilical cords. These cells are intended for use in regenerative medicine to promote tissue repair and modulate inflammation through paracrine signaling and potential cellular differentiation. The product is manufactured as medical-grade material for research use and is being explored for applications in bone repair, wound healing, burn treatment, and anti-aging. While marketed for various regenerative purposes, it has been the subject of FDA regulatory scrutiny regarding its marketing claims and classification as a biological drug product.

Brand names
REGENERELLE
Other names
Wharton's Jelly mesenchymal stem cellsWJ-MSCshuman mesenchymal stem cellshMSCs

Beyond the preview

Go deeper on REGENERELLE.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on REGENERELLE.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call